World Market for Cancer Diagnostics, 2015 Edition - The Race For Prevention Supports a Market for Innovative Diagnostic Tools

Oct 14, 2015, 03:10 ET from Research and Markets

DUBLIN, Oct. 13, 2015 /PRNewswire/ --

Research and Markets( has announced the addition of the "The World Market for Cancer Diagnostics, 6th Edition" report to their offering.

The World Market for Cancer Diagnostics, 6th Edition provides authoritative and complete analysis of the cancer testing industry, with expert market sizing and opportunity assessment.  Kalorama has, in five previous editions, defined the oncology testing market.

This report is written from the point of view of diagnostic modalities for the detection and management of cancer and in particular solid tumors. The technology to detect cancers of the blood - lymphomas, myelomas and leukemia - is mature and well established. The routine complete blood count screens for blood cell abnormalities and is followed by bone marrow analysis and flow cytometric studies of the blood cell surface markers. These to arrive at a more specific diagnosis. As such this report does not discuss area of hematological cancer diagnosis in great detail.

This latest report contains detailed market data on the following IVD segments for their use in cancer diagnostics:

  • IVD Market for Cancer Tests
  • Service Test Market
  • Next-Generation Sequencing Technologies
  • Tissue Function Tests
  • PSA, CEA and Other Immunoassays
  • Flow Cytometry
  • Pap and HPV Testing
  • FOB, and Other Rapid Tests
  • Molecular Oncology Assays
  • Tissue Microrrays
  • Methylated DNA
  • In situ hybridization (ISH)
  • Immunohistochemistry (IHC)
  • Circulating Tumor Cells
  • Companion Testing, CDX Products and Deals

Key Topics Covered:

One: Executive Summary

Two: Introduction

Three: Technologies Used In Cancer Diagnostics

Four: Cancer Diagnostics - Applications

Five: Cancer Diagnostic Markets

Six: Deals - Cancer Diagnostics

Seven: Cancer Diagnostics - Market Drivers And Challenges

Eight: In Vitro Cancer Diagnostics Market Analysis

Nine: Company Profiles: Cancer Diagnostic Companies

For more information visit

Media Contact: Laura Wood , +353-1-481-1716,

SOURCE Research and Markets